港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

1,035.357

+6.6380.65%

涨家数：12

跌家数：6

平家数：- -

市盈率：- -

高：1,046.140

开：1,028.442

低：1,028.442

收：1,028.719

数据加载中...

中港股市 | 比亚迪6月销量新高，但降价效益与盈利承压引关注 | 中国两大AI芯片新创公司寻求IPO，目标合计募资120亿人民币

“稻米造血”之父即将迎来一个IPO

东四十条资本

《股市简讯》中国生物制药涨4.9%，国家药监局批准其联合疗法治疗软组织肉瘤

京东健康盘中异动大幅跳水3.02%

港股异动｜创新药股走强，三生制药涨超8%，政策支持加速医药创新

石药集团盘中异动快速拉升5.06%报8.090港元

四环医药(00460)出现大手买入200万股，成交价$1.13，涉资226万

阿斯达克财经

中国中药(00570)出现大手买入85.6万股，成交价$2.26，涉资193.456万

阿斯达克财经

【港股异动 | 创新药概念表现强势两部门发布16条举措支持创新药医药创新动能加速】智通财经APP获悉，创新药概念表现

同源康医药-B盘中异动早盘急速拉升5.07%报22.800港元

【券商聚焦】中信证券：医药真创新和真国际化时代将迎来回报有望带动板块稳步向上

中信证券研报指出我国创新药发展已经取得阶段性成效延续我们2025年下半年投资策略观点拥抱创新驱动和国际化+自主可控+院外

轩竹生物上市梦坎坷：持续亏损净资产缩水，研发人员暴减七成

港湾商业观察

国盛宏观：四大维度对比各行业“内卷”压力

AI陪聊，抢得走心理医生的“饭碗”吗？｜行业 Mapping

隐藏的代谢巨头，正在崛起

国药控股新疆新特参茸药业有限公司中标乌鲁木齐国际医院呼吸机采购项目

万春医药上涨5.53%，报2.48美元/股，总市值9998.45万美元

比亚迪叫停“价格战”？这是产业与科技竞争的缩影

医疗健康：政策进一步支持全链条支持创新药发展

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1515/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":1035.3567,"timestamp":1751428799932,"preClose":1028.7189,"halted":0,"volume":398142513,"delay":0,"changeRate":0.006453,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午间休市","change":6.637817,"latestTime":"07-02 12:00:00","open":1028.4424,"high":1046.1401,"low":1028.4424,"amount":2757953719,"amplitude":0.017204,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1751432400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1751419800000,1751428800000],[1751432400000,1751443200000]],"pbRate":1.747818,"peRate":23.357005,"turnoverRate":0.005407,"increases":12,"decrements":6,"flats":0,"marketCap":711861031296,"floatMarketCap":588132662144},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1046.1401,"amplitude":0.017204,"preClose":1028.7189,"low":1028.4424,"pbRate":"1.747818","latestPrice":1035.3567,"volume":398142513,"delay":0,"open":1028.4424,"prevYearClose":787.97723,"prevWeekClose":1032.682,"prevMonthClose":1028.719,"prevQuarterClose":1028.719,"fiveDayClose":1015.72,"twentyDayClose":968.878,"sixtyDayClose":887.176,"secType":"PLATE","market":"HK","turnoverRate":0.005407,"peRate":23.357005,"marketCap":711861031296,"floatMarketCap":588132662144,"timestamp":1751428799932,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":12,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548855311","title":"中港股市 | 比亚迪6月销量新高，但降价效益与盈利承压引关注 | 中国两大AI芯片新创公司寻求IPO，目标合计募资120亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2548855311","media":"辉立环球SG","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548855311?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 11:17","pubTimestamp":1751426255,"startTime":"0","endTime":"0","summary":"比亚迪6月销量创新高，但降价效益与盈利承压引关注港股中国电动汽车巨头比亚迪周二公布，6月共售出377,628辆汽车，同比增长10%，创下2025年以来最佳单月表现。然而，大规模降价行动已对比亚迪的盈利能力构成压力，导致投资者担忧毛利下滑，公司市值自5月底以来已蒸发超过200亿美元。吉利同时上调了2025年全年交付目标11%，至300万辆。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702112612a4ca3276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702112612a4ca3276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0143863784.USD","LU0164872284.USD","LU0320764599.SGD","BK1504","LU0516423174.USD","LU0531971595.HKD","LU1808992512.USD","LU0315178854.USD","LU0359202008.SGD","LU0823414551.USD","LU0259732245.USD","LU1794554557.SGD","LU0856984785.SGD","BK1515","LU2476274308.USD","LU0823426308.USD","LU0327786744.USD","LU0823414478.USD","SG9999015945.SGD","IE00BD6J9T35.USD","002594","LU0164865239.USD","LU0588546209.SGD","BK1607","BK1610","LU1868837722.USD","LU1720050803.USD","LU0588545904.SGD","LU2294711713.HKD","LU1961090484.USD","LU0274383008.USD","BK1580","LU0254981946.USD","LU0143863198.USD","LU0348766576.USD","81211","01211","LU0588545730.USD","LU0348825331.USD","LU0449509016.USD","HYDD.SI","LU1023057109.AUD","LU0561508036.HKD","LU0359201885.HKD","LU0865486749.SGD","LU0509642566.USD","LU0572944931.SGD","BYDDY","LU0449515922.USD","00285"],"gpt_icon":1},{"id":"2548785811","title":"“稻米造血”之父即将迎来一个IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2548785811","media":"东四十条资本","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548785811?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 10:34","pubTimestamp":1751423659,"startTime":"0","endTime":"0","summary":"等待2年，“稻米造血”之父迎来一个IPO从2022年底首次申报，到如今首发过会，禾元生物已等待2年时间。履历显示，杨代常是分子遗传学领域的元老级人物，为武汉大学生命科学学院与国际水稻研究所联合培养的分子遗传学博士，被誉为“稻米造血”之父。究其原因，在于一二级市场价差不断缩小，甚至出现倒挂，这使得投资机构对于Pre-IPO项目望而却步。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702103609a4ca18ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702103609a4ca18ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","01099","BK1515","688235","BK1197","LU1115378108.SGD","LU0640798160.USD"],"gpt_icon":0},{"id":"2548830172","title":"《股市简讯》中国生物制药涨4.9%，国家药监局批准其联合疗法治疗软组织肉瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2548830172","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548830172?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 10:16","pubTimestamp":1751422593,"startTime":"0","endTime":"0","summary":"《股市简讯》中国生物制药涨4.9%，国家药监局批准其联合疗法治疗软组织肉瘤* 泰国富豪谢氏家族旗下制药公司--中国生物制药1177.HK周三早盘涨幅扩大至4.9%。* 该公司此前公告称，集团开发的盐酸安罗替尼胶囊联合化疗方案，已获得中国国家药品监督管理局批准，用于局部晚期或转移性软组织肉瘤患者的一线治疗。* 中国生物制药今年迄今劲涨69.7%，同期恒生指数.HSI大幅上扬20.5%。* 恒生香港上市生物科技指数.HSHKBIO盘中一度升3.1%。（完）更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文；审校 张喜良) ((kaiwen.xu@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL4S3SZ05J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","IE00BZ08YR35.GBP","BK1589","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1515"],"gpt_icon":0},{"id":"2548683024","title":"京东健康盘中异动 大幅跳水3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548683024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548683024?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 10:06","pubTimestamp":1751421966,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘10时06分，京东健康股票出现波动，股价大幅跳水3.02%。截至发稿，该股报41.700港元/股，成交量188.526万股，换手率0.06%，振幅4.07%。京东健康股票所在的药品分销行业中，整体跌幅为0.33%。其相关个股中，思派健康、百信国际、叮当健康涨幅较大，振幅较大的相关个股有思派健康、叮当健康、方舟健客，振幅分别为35.13%、9.26%、6.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702100606a729787b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702100606a729787b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0051755006.USD","BK1591","BK1142","06618","BK1589","BK1571","LU0456827905.SGD","BK1615","BK1247","BK1583","BK1515","86618"],"gpt_icon":0},{"id":"2548113832","title":"港股异动｜创新药股走强，三生制药涨超8%，政策支持加速医药创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2548113832","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548113832?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 10:03","pubTimestamp":1751421795,"startTime":"0","endTime":"0","summary":"中信证券认为，我国创新药发展已经取得阶段性成效，《若干措施》有利于进一步完善支持创新药高质量发展。考虑到创新药板块除海外斩获外，新增国内政策大力支持，中信证券认为医药真创新和真国际化时代将迎来回报，有望带动板块稳步向上。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1312847.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动｜创新药股走强，三生制药涨超8%，政策支持加速医药创新","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01530","BK1191","BK1161","BK1515","BK1574","BK1587","BK1593","BK4614","BK1588","BK1583"],"gpt_icon":0},{"id":"2548287830","title":"石药集团盘中异动 快速拉升5.06%报8.090港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548287830","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548287830?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 10:02","pubTimestamp":1751421744,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘10时02分，石药集团股票出现波动，股价大幅上涨5.06%。截至发稿，该股报8.090港元/股，成交量8043.5万股，换手率0.70%，振幅2.73%。资金方面，该股资金流入3.50893亿港元，流出2.1557亿港元。石药集团股票所在的药品行业中，整体涨幅为0.98%。其相关个股中，三生制药、和黄医药、石药集团涨幅较大，振幅较大的相关个股有泰德医药、精优药业、三生制药，振幅分别为9.74%、9.52%、5.92%。恒瑞连续多年在全球新药进展榜单中位居第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070210022795334e0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070210022795334e0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1152091168.USD","LU0140636845.USD","LU1951186391.HKD","IE00B543WZ88.USD","LU1226288170.HKD","LU1226287875.USD","LU0880133367.SGD","IE00B5MMRT66.SGD","LU1226288253.USD","LU1152091754.HKD","IE0008369823.USD","LU0326950275.SGD","BK1191","LU1807302812.USD","LU0501845795.SGD","LU0072913022.USD","BK1521","IE00BZ08YR35.GBP","LU1008478684.HKD","SG9999004220.SGD","LU1226287529.USD","IE00BZ08YT58.USD","IE0008368742.USD","IE00B031HY20.USD","LU1960683339.HKD","LU0315179316.USD","LU0067412154.USD","LU1226287792.SGD","01093","LU1993786604.SGD","IE00BZ08YS42.EUR","BK1515"],"gpt_icon":0},{"id":"2548837991","title":"四环医药(00460)出现大手买入200万股，成交价$1.13，涉资226万","url":"https://stock-news.laohu8.com/highlight/detail?id=2548837991","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548837991?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 09:40","pubTimestamp":1751420400,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在上午09:40出现大手买入，成交量为200万，成交价为港币$1.13，涉资226万。至目前为止，股价升1.802%，今日最高价为$1.13，而最低价为$1.11，总成交量为1.426千万股，总成交金额港币$1.604千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2507021561/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1191","BK1600","BK1593","00460"],"gpt_icon":0},{"id":"2548379628","title":"中国中药(00570)出现大手买入85.6万股，成交价$2.26，涉资193.456万","url":"https://stock-news.laohu8.com/highlight/detail?id=2548379628","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548379628?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 09:40","pubTimestamp":1751420400,"startTime":"0","endTime":"0","summary":"[大手成交]中国中药(00570)在上午09:40出现大手买入，成交量为85.6万，成交价为港币$2.26，涉资193.456万。至目前为止，股价升1.81%，今日最高价为$2.26，而最低价为$2.21，总成交量为579万股，总成交金额港币$1.297千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2507021579/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1606","00570","BK1191"],"gpt_icon":0},{"id":"2548832118","title":"【港股异动 | 创新药概念表现强势 两部门发布16条举措支持创新药 医药创新动能加速】智通财经APP获悉，创新药概念表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832118","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548832118?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 09:37","pubTimestamp":1751420248,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1655091616.SGD","BK0183","BK0196","BK1593","BK1574","LU1064130708.USD","BK4588","BK0028","159938","LU0405327148.USD","BK4007","09939","LU1997245094.SGD","159992","01530","BK1588","BK1515","LU2495084118.USD","LU2148510915.USD","01952","LU2488822045.USD","01276","BK4531","BK0239","LU0405327494.USD","LU2328871848.SGD","LU1997244956.HKD","BK1587","BK1161","BK1583","600276","LU1064131003.USD","BK0060","LU1328615791.USD","HCM","LU1969619763.USD","06978","BK1191","BK0188","BK0012","00013","LU1997245177.USD","BK4585"],"gpt_icon":0},{"id":"2548799837","title":"同源康医药-B盘中异动 早盘急速拉升5.07%报22.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548799837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548799837?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 09:33","pubTimestamp":1751419995,"startTime":"0","endTime":"0","summary":"2025年07月02日早盘09时33分，同源康医药-B股票出现波动，股价快速拉升5.07%。截至发稿，该股报22.800港元/股，成交量21.6万股，换手率0.06%，振幅6.45%。资金方面，该股资金流入302.925万港元，流出99.9475万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，华昊中天医药-B、加科思-B、云顶新耀涨幅较大，振幅较大的相关个股有华昊中天医药-B、科笛-B、百奥赛图-B，振幅分别为51.47%、11.38%、7.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209331597969fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209331597969fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09939","02410","BK1515"],"gpt_icon":0},{"id":"2548683193","title":"【券商聚焦】中信证券：医药真创新和真国际化时代将迎来回报 有望带动板块稳步向上","url":"https://stock-news.laohu8.com/highlight/detail?id=2548683193","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548683193?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 08:54","pubTimestamp":1751417678,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研报指出，我国创新药发展已经取得阶段性成效，拥抱创新驱动和国际化+自主可控+院外营销模式改革将是下半年相对更有确定性的布局方向。考虑到创新药板块除海外斩获外，新增国内政策大力支持，医药真创新和真国际化时代将迎来回报，有望带动板块稳步向上。该机构建议横向维度上，下半年围绕创新驱动和国际化+自主可控+院外营销模式改革三个领域进行布局，尤其是最具贝塔效应的创新药领域。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1961439","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","BK0028","LU0405327494.USD","BK0276","LU1997245177.USD","LU2328871848.SGD","BK1574","09939","159938","BK1191","LU2289578879.USD","BK1589","LU1655091616.SGD","600030","LU2148510915.USD","BK1588","LU1997244956.HKD","BK1161","LU1969619763.USD","BK1583","LU1794554557.SGD","BK0012","BK1521","LU1064130708.USD","LU1328615791.USD","01801","BK0196","LU1997245094.SGD","03692","BK0183","06030","LU2488822045.USD","LU1720050803.USD","LU1064131003.USD","BK1564","BK1516","00013","BK0188","BK1587","LU0405327148.USD","BK1147","BK1515"],"gpt_icon":0},{"id":"2548839611","title":"中信证券研报指出我国创新药发展已经取得阶段性成效延续我们2025年下半年投资策略观点拥抱创新驱动和国际化+自主可控+院外","url":"https://stock-news.laohu8.com/highlight/detail?id=2548839611","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548839611?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 08:30","pubTimestamp":1751416233,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","LU1064131003.USD","159938","BK0012","BK1564","LU2495084118.USD","LU1655091616.SGD","LU1064130708.USD","LU0405327494.USD","BK0196","LU1997245094.SGD","BK1161","BK1516","BK0183","LU1794554557.SGD","09939","LU1720050803.USD","BK1574","LU1997245177.USD","LU1328615791.USD","06978","LU2148510915.USD","LU1997244956.HKD","600030","LU2289578879.USD","BK1147","BK0276","159992","LU0405327148.USD","BK1521","06030","BK0188","BK0028"],"gpt_icon":0},{"id":"2548316478","title":"轩竹生物上市梦坎坷：持续亏损净资产缩水，研发人员暴减七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2548316478","media":"港湾商业观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548316478?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 08:20","pubTimestamp":1751415600,"startTime":"0","endTime":"0","summary":"2023年3月8日，在上交所2023年第6次上市审核委员会审议会议中，轩竹生物的首发上会遭暂缓审议。此次分拆的主要原因包括增强轩竹生物的独立性和融资能力。据悉，轩竹生物聚焦于消化、肿瘤及非酒精性脂肪性肝炎等重大疾病领域。而引发外界关注的是，同一时间轩竹生物净资产分别为11.1亿元、9.57亿元和8.91亿元，呈现持续缩水态势。轩竹生物表示，公司计划于未来两年招募30名销售人员，并于未来三年在全国委聘15至20家新分销商。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/stockzmt/2025-07-02/doc-infczvkt4631162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159982","BK4008","BK1515","BK1191","BK1600","BK4588","BK1593","00460","PPI","BK4500","BK4585","ALK","BK4570"],"gpt_icon":0},{"id":"2548052834","title":"国盛宏观：四大维度对比各行业“内卷”压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2548052834","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548052834?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 08:14","pubTimestamp":1751415240,"startTime":"0","endTime":"0","summary":"　　核心观点：基于“价格、利润、应付账款、产能利用率”4大维度，截至2025年一季度，各行业“内卷”压力如下：。　　2、新兴行业中，电子设备、化学制品、汽车、医药等行业的“内卷”压力较大，尤其是汽车、医药的价格压力较大。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/stockptd/2025-07-02/doc-infczvkq5945135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","09939","BK1574","BK1161"],"gpt_icon":0},{"id":"2548883968","title":"AI陪聊，抢得走心理医生的“饭碗”吗？｜行业 Mapping","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883968","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548883968?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 08:05","pubTimestamp":1751414700,"startTime":"0","endTime":"0","summary":"AI公司们几乎想要无死角地覆盖医院内的每个角落。其中，一个备受关注的方向就是AI心理健康。的确，AI具备成为“廉价心理咨询师”的潜力。其中，互联网大厂成为这一波AI+心理健康热潮中，最重要的先行者。且后续问卷调查称，参与者和Therabot建立的信任“与人类治疗师相当”。在专业的医疗机构中，心理科和精神科“往往是密切合作的”。但在AI这里，缺少后续的衔接机制，就意味着它永远无法真正达到一名“心理医生”的水准。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-07-02/doc-infczraq8192623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4587","BK1589","BK4514","BK4504","BK4543","BK1247","BK4579","BK4552","LU0051755006.USD","LU0359202008.SGD","LU1115378108.SGD","BK4526","86618","BIDU","BK1515","LU0640798160.USD","BK4077","BK1583","BK1591","BK4585","BK4535","BK1615","BK4548","BK4531","BK1571","BK4612","BK4602","LU1023057109.AUD","IE00B0JY6N72.USD","BK4588","06618","BK4574","LU0359201612.USD","LU0287142896.SGD","LU0173614495.USD","BK1142","LU0456827905.SGD","BK4614"],"gpt_icon":0},{"id":"2548836091","title":"隐藏的代谢巨头，正在崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2548836091","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548836091?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 07:58","pubTimestamp":1751414325,"startTime":"0","endTime":"0","summary":"而在众多参与者之中，一个隐藏的代谢巨头正在崛起——东阳光药正以GLP-1多靶点激动剂为关键锚点，构建起跨越糖尿病、肥胖、NASH的庞大代谢版图，开辟出了自己的突围路径。因此，HEC-007具有良好的成药性，有望为肥胖患者带来新的治疗方案。与目前已上市的GLP-1受体激动剂相比，GLP-1/FGF21双靶点激动剂在降糖、减重及有效缓解NASH方面上均具有优势。目前，东阳光药正在中国进行针对2型糖尿病适应症的II期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702080642a7293f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702080642a7293f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2548833070","title":"国药控股新疆新特参茸药业有限公司中标乌鲁木齐国际医院呼吸机采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2548833070","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548833070?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 06:47","pubTimestamp":1751410022,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年06月30日，乌鲁木齐国际医院发布了公共卫生临床楼医疗设备采购项目（第二包：呼吸机）的中标结果公告。该项目由国药控股新疆新特参茸药业有限公司中标，中标金额为2880000元。采购地点位于新疆维吾尔自治区。本次公告类型为中标结果公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702064825953316e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702064825953316e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1115378108.SGD","01099","LU0640798160.USD","BK1500","BK1197","BK1515"],"gpt_icon":0},{"id":"2548385889","title":"万春医药上涨5.53%，报2.48美元/股，总市值9998.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548385889","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548385889?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 00:35","pubTimestamp":1751387707,"startTime":"0","endTime":"0","summary":"7月2日，万春医药盘中上涨5.53%，截至00:35，报2.48美元/股，成交6888.0美元，总市值9998.45万美元。财务数据显示，截至2024年06月30日，万春医药收入总额100.0万美元，同比增长14.29%；归母净利润-726.2万美元，同比增长42.91%。大事提醒：5月5日，万春医药将披露2024财年年报。资料显示，万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/02003551425456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159938","BK1161","BK1574","09939","BK1515"],"gpt_icon":0},{"id":"2548288482","title":"比亚迪叫停“价格战”？这是产业与科技竞争的缩影","url":"https://stock-news.laohu8.com/highlight/detail?id=2548288482","media":"观点网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548288482?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 00:21","pubTimestamp":1751386860,"startTime":"0","endTime":"0","summary":"比亚迪行动迅速，进行了调整。同时，从7月1日起对购车政策进行大调整——被媒体认为是叫停“价格战”。这是当前中国产业与科技竞争中的一个缩影。《意见》是继自然资源部等机构发布指导目录后的首个明确响应这一方向、从供给端严控工业标准厂房增量的地方政策。8月12-15日，观点机构将在海南举办2025博鳌房地产论坛系列活动，其中，针对产业物流科技版块，将以“飞驰时代”为主题，举办2025博鳌产业科技大会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070202424697963b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070202424697963b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0314109678.HKD","LU0164872284.USD","LU0320764599.SGD","LU0516423174.USD","LU0531971595.HKD","LU0823426480.USD","LU0856984785.SGD","LU0516422952.EUR","LU0516422366.SGD","LU0979878070.USD","BK1515","LU2357125470.USD","LU1880383440.USD","LU0588545490.SGD","LU1251922891.USD","LU2360107325.USD","LU2399975544.HKD","LU0823414478.USD","SG9999015945.SGD","LU0531970944.HKD","LU0819121731.USD","LU1188198961.HKD","002594","LU1719994722.HKD","LU1868837722.USD","LU2097828474.EUR","LU0289739343.SGD","LU1720050803.USD","LU2294711713.HKD","LU0819123356.HKD","LU1242518931.SGD","BK1539","LU0214875030.USD","LU0211977185.USD","81211","01211","LU2153592121.USD","LU2348774022.SGD","LU0289960550.SGD","LU0269904917.USD","HYDD.SI","BK1119","LU0084288322.USD","LU1023057109.AUD","LU1303224171.USD","SG9999006514.SGD","LU0572944931.SGD","BYDDY","SG9999001226.SGD","00285"],"gpt_icon":1},{"id":"2548836816","title":"医疗健康：政策进一步支持全链条支持创新药发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2548836816","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548836816?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 00:00","pubTimestamp":1751385600,"startTime":"0","endTime":"0","summary":"行业近况7 月1 日，国家医保局、国家卫生健康委关于印发《支持创新药高质量发展的若干措施》的通知1，提出加强对创新药研发支持、支持创新药进入医保目录和商业健康保险创新药品目录、鼓励创新药临床应用、提高创新药多元支付能力、强化组织保障等5 方面16 条举措，我们预计此政策有望进一步完善全链条支持创新药发展举措，推动创新药高质量发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702074625a4c9c4df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702074625a4c9c4df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE0008369823.USD","LU1951186391.HKD","BK1574","SG9999004220.SGD","LU0326950275.SGD","LU0140636845.USD","IE00BZ08YR35.GBP","LU0067412154.USD","06990","IE0008368742.USD","LU0072913022.USD","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1226288170.HKD","09688","LU1226288253.USD","LU1152091754.HKD","LU1993786604.SGD","BK1521","LU0501845795.SGD","LU1226287792.SGD","IE00BZ08YT58.USD","BK1191","IE00B543WZ88.USD","06978","06160","LU0315179316.USD","LU1960683339.HKD","01093","LU1226287529.USD","BK1161","LU1226287875.USD","LU0880133367.SGD","01801","IE00B031HY20.USD","LU1152091168.USD","LU1807302812.USD","09926","IE00B5MMRT66.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":26,"pageCount":1,"totalSize":512,"code":"91000000","status":"200"}]}}